NCT01011881

Brief Summary

The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 10, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 11, 2009

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
Last Updated

June 9, 2016

Status Verified

June 1, 2016

Enrollment Period

1.3 years

First QC Date

November 10, 2009

Last Update Submit

June 8, 2016

Conditions

Keywords

pleuritisempyemaprocalcitonin

Study Arms (1)

patients with pleuritis

Other: pleural level of procalcitonin

Interventions

no intervention

patients with pleuritis

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with pleuritis

You may qualify if:

  • Pleuritis
  • Hospitalisation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80000, France

Location

MeSH Terms

Conditions

PleurisyEmpyema, PleuralEmpyema

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPleural DiseasesRespiratory Tract DiseasesSuppurationInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2009

First Posted

November 11, 2009

Study Start

October 1, 2009

Primary Completion

February 1, 2011

Study Completion

February 1, 2011

Last Updated

June 9, 2016

Record last verified: 2016-06

Locations